A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia
Clinical trial NCT01655680 · COMPLETED
Trial details
- NCT number
- NCT01655680
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2014-04-01
- Enrollment
- 432
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.